Select Page
Event info
Date:09 Apr
Time:17:00 - 20:00
Venue:Medicon Valley Alliance, Copenhagen S

MVA Oncology Network Meeting

Welcome to MVA Oncology Network and our 5th meeting!

Biomarkers – opportunities and challenges in oncology drug development

Biomarker measurements have become an essential component of oncology drug development, particularly so in this era of targeted therapies.

What does it take to get a biomarker from discovery to translation to commercialization? Are we making the most out of the biomarker expertise we have in the Medicon Valley region? 

Medicon Valley Alliance together with Biopeople/Biomarkers as emerging growth area now invites you to MVA Oncology Network and our 5th  meeting covering the topic “Biomarkers – opportunities and challenges in oncology drug development”:
Date: 9 April 2018
Time: 17:00 – 20:00
Host: Biopeople/Biomarkers as emerging growth area
Venue: Medicon Valley Alliance, Auditorium, Arne Jacobsens Allé 15, Ørestad City, 2300 Copenhagen
Cost: Free of charge for MVA members

Sign up

The network
MVA Oncology Network is a professional and social network for professors, PI and corporate level executives from the regional oncology eco-system. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region.
Joining the network is free of charge and is limited to Medicon Valley Alliance members only. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically make you able you to join the oncology network.



Registration, networking and a bite to eat – meet the fellow participants

17:30-17.35  Welcome 
Petter Hartman, CEO, Medicon Valley Alliance
Jane Nøhr, Cluster Manager, BioPeople
7:35-17:40 Sponsor of the event
Peter Holm, Partner, European Patent Attorney, HØIBERG
17:40-18.10 “Who are we?” 4 x 5 minute corporate presentations
Ole Thastrup, CEO, 2cureX
Peter Buhl Jensen, CEO, MPI
Barry van der Strate, Director, Bioanalytical  Services, PRA Health Sciences
Johan Vallon-Christersson, Researcher, Lund University
18:10-18.40 Keynote Speaker
Systems medicine methods for identification of stratified cancer therapies and their predictive biomarkers

Krister Wennerberg, Prof., University of Copenhagen
18:40-18.55 Biomarkers as emerging growth area
Jane Nøhr, Cluster Manager, BioPeople
18:55-19:10 Biomarkers as a platform for clinical success and reimbursement
Henrik Winther, SVP Business Development, Immunovia AB
19:10-19:30 Future joint Nordic Biomarker initiative?
Nils Brünner, Prof., University of Copenhagen
19:30-20:00 Networking and a light snack



In collaboration

   mva logo


logo LU logo uni_copenhagen